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Purpose: Progressive cartilage destruction leading to joint malfunction is one of the most prominent 
features of osteoarthritis (OA). At present this pathology has no cure and current treatments are mostly 
symptomatic, not being able to stop or retard the progression of the disease. Hydrogen sulphide is a small 
gaseous molecule that has shown to prevent cartilage degradation as well as to exert anti-inflammatory 
effects in in vitro models of OA. The purpose here was to evaluate the effects of administering an H2S-
producing compound, intra-articularly, in an experimental model of OA. 
 
Methods: Experimental OA was induced in a rodent (Wistar female rats) model by transection of the 
medial collateral ligament and removal of the medial meniscus of the left knee. The right knee was 
employed as control. Animals were randomized into three groups (6 rats per group). In one group (intra-
articular sulphide, IS), GYY4137, a well-known H2S producing compound, was delivered intra-articularly 
(200 μM in saline, 50 μl), with one single injection at day 7. The second group (intra-articular control, IC) 
received vehicle (saline) also in one single injection (50 μl, at day 7) serving as treatment control. The 
third group received no treatment and served as surgical control (C). Macroscopy clinical evaluation of 
the animals was performed at days 0 (before surgery), 7, 15 and 40 (euthanasia) including indirect 
evaluation of pain levels using a Rotarod performance test. Histopathological changes in articular 
cartilage and synovium were evaluated using a semi-quantitative scoring system (Mankin Score, MS) and 
a synovitis grading system (Krenn Score, KS), respectively. 
 
Results: Seven days after surgery animals in all 3 groups showed worse performance in the Rotarod test, 
with significant increases in the number of falls (except IC) and reductions in the time to first fall (Table 
1). After 40 days, animals in the C group showed no significant improvement in either of these 
parameters. In the intra-articular control (IC) the number of falls had returned to pre-surgical levels, and 
in the animals that received intra-articular H2S (IS), results were significantly better with respect to both 
day 0 and both control groups (C and IC) (Table 1). Times to 1
st
 fall were also significantly better in the 
IS group versus C and IC groups both at days 15 and 40. 
Cartilage deterioration as a result of surgery was evaluated with the Mankin Scoring system. Tibial 
plateaus (TP) and femoral condyles (FC) in both the medial (M) and lateral (L) compartments in each 
knee were evaluated (Table 2). There were no significant differences among groups in the lateral 
compartment, neither when considering TP and FC separately nor for the compartment as a whole. 
Conversely, scores in the medial compartment were significantly better in the animals treated with intra-
articular H2S vs the Control group, both when considering TP or FC separately, and for the compartment 
as a whole (Table 2). Synovial inflammation was evaluated with the Krenn score, and no significant 
differences were found among the three groups. 
 
Conclusions: This study demonstrates that a single dose of a H2S-producing compound (200 μM 
GYY4137 in 50 μl saline) administered intra-articularly can reduce the severity of cartilage destruction in 
an experimental model of OA as compared to no treatment or a vehicle control. Further, results from the 
performance test suggest that exogenous H2S administration in this manner also leads to a reduction of 
pain levels in the animals. Thus, these results confirm the potential of H2S as a pharmacological treatment 
in OA, and provide encouragement to investigate this possibility in OA patients through clinical trials. 
Table 1. Number of falls within a 5-min period, and time to first fall (s) for the three groups. 
Group 
Falls (n ± sd)  Time to 1st fall (s) 
T0 T7 T15 T40  T0 T7 T15 T40 
          
C 0.83 ± 0.75 4.00 ± 0.89# 4.00 ± 0.89# 3.67 ± 1.75#  233.7 ± 77.8 57.17 ± 35.39# 90.3 ± 67.5# 77.8 ± 40.2# 
IC 1.67 ± 1.03 3.33 ± 1.75 2.17 ± 0.98 2.00 ± 0.89  209.2 ± 78.2 31.67 ± 11.74# 90.8 ± 20.9# 143.3 ± 50.3 
IS 1.33 ± 0.82 4.00 ± 1.55# 2.50 ± 1.05 0.00 ± 0.00#*$  265.3 ± 58.8 78.50 ± 65.90# 196.3 ± 81.3*$ 300.0 ± 0.0*$ 
          
 
C: control group; IC: intra-articular control (saline); IS: intra-articular sulphide (IS, 200 μM GYY4137). n = 6 in each group. 
#P<0.05 with respect to T0; *P<0.05 with respect to C; $P<0.05 with respect to IC. 
Table 2. Mankin Score grading of cartilage destruction. 
Group Medial compartment Lateral compartment MTP MFC LTP LFC Whole joint 
        
C 12.50 ± 0.6 4.0 ± 0.0 12.5 ± 0.7 12.5 ± 0.7 4.0 ± 0.0 4.0 ± 0.0 8.3 ± 4.6 
IC 10.0 ± 1.7* 7.3 ± 4.0 9.7 ± 2.3 10.3 ± 1.2 6.7 ± 4.0 8.0 ± 1.7 8.7 ± 2.6 
IS 7.0 ± 1.3* 3.8 ± 1.7 7.7 ± 0.6* 6.3 ± 1.5* 3.0 ± 0.0 4.5 ± 3.5 5.7 ± 2.3 
        
 
C: control group; IC: intra-articular control (saline); IS: intra-articular sulphide (IS, 200 μM GYY4137); M: medial; L: lateral; TP: 
tibial plateau; FC: femoral condyle. n = 3 in each group. *P<0.05 with respect to C. 
 
 
